Growth Metrics

Nu-Med Plus (NUMD) Cash from Financing Activities (2016 - 2021)

Nu-Med Plus' Cash from Financing Activities history spans 10 years, with the latest figure at $30000.0 for Q1 2021.

  • Quarterly results put Cash from Financing Activities at $30000.0 for Q1 2021, down 71.81% from a year ago — trailing twelve months through Dec 2021 was $30000.0 (down 94.97% YoY), and the annual figure for FY2025 was $46267.0, changed.
  • Cash from Financing Activities for Q1 2021 was $30000.0 at Nu-Med Plus, down from $228260.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $379000.0 in Q1 2017 to a low of $6132.0 in Q1 2018.
  • The 5-year median for Cash from Financing Activities is $106439.0 (2020), against an average of $123017.6.
  • The sharpest move saw Cash from Financing Activities soared 10844.24% in 2017, then tumbled 98.38% in 2018.
  • Year by year, Cash from Financing Activities stood at $80910.0 in 2017, then soared by 76.22% to $142580.0 in 2018, then tumbled by 36.94% to $89906.0 in 2019, then soared by 153.89% to $228260.0 in 2020, then tumbled by 86.86% to $30000.0 in 2021.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $30000.0, $228260.0, and $126412.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.